| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 50, 1071-1074, Copyright © 1980 by Endocrine Society
ARTICLES |
SL Swartz, GH Williams, NK Hollenberg, RG Dluhy and TJ Moore
The primacy of angiotensin II as the mediator of the adrenal's response to sodium restriction is controversial. We administered the oral converting enzyme inhibitor, captopril (SQ 14225), to test whether reduction of angiotension II generation for 26 h in sodium-restricted subjects would lower plasma aldosterone levels to values observed in subjects on a high sodium intake. Accordingly, plasma angiotensin II and aldosterone levels were measured in nine recumbent normal subjects on high (200 meq) and low (10 meq) sodium intakes and low sodium intake with captopril (12.5--25 mg four times a day for 26 h). Captopril reduced the sodium-restricted angiotensin II levels from 31 +/- 6 to 13 +/- 2 pg/ml, which was indistinguishable from that measured on the high sodium intake (11 +/- 2 pg/ml). Concomitantly, aldosterone levels were reduced from 25 +/- 4 to 7 +/- 1 ng/dl, which was similar to the high sodium value (8 +/- 1 ng/dl). There were no significant changes in serum sodium, cortisol, or potassium at the three sampling times. Thus, the complete suppression of the sodium-restricted levels of both angiotensin II and aldosterone into the high sodium range by captopril provides strong support for the hypothesis that the renin-angiotensin system is the prime mediator of the adrenal's response to sodium restriction.
This article has been cited by other articles:
![]() |
Z. Wu, W. Zheng, and K. Sandberg Estrogen Regulates Adrenal Angiotensin Type 1 Receptors by Modulating Adrenal Angiotensin Levels Endocrinology, April 1, 2003; 144(4): 1350 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. IBRAHIM and T. H. HOSTETTER Role of Dietary Potassium in the Hyperaldosteronism and Hypertension of the Remnant Kidney Model J. Am. Soc. Nephrol., April 1, 2000; 11(4): 625 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text] |
||||
![]() |
S. K. Gandhi, J. Gainer, D. King, and N. J. Brown Gender Affects Renal Vasoconstrictor Response to Ang I and Ang II Hypertension, January 1, 1998; 31(1): 90 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gandhi, D. H. Ryder, and N. J. Brown Losartan Blocks Aldosterone and Renal Vascular Responses to Angiotensin II in Humans Hypertension, December 1, 1996; 28(6): 961 - 966. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |